Russell Investments Group
KRTX

Russell Investments Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Russell Investments Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127
Closed -$40.2K – 3391
2023
Q4 		$40.2K Buy
127
+103
+429% +$20K ﹤0.01% 2658
2023
Q3 		$4.06K Sell
24
-8,104
-100% -$1.52M ﹤0.01% 3179
2023
Q2 		$1.76M Buy
8,128
+2,548
+46% +$546K ﹤0.01% 1634
2023
Q1 		$1.01M Buy
5,580
+5,451
+4,226% +$1.04M ﹤0.01% 1959
2022
Q4 		$25.3K Hold
129
– – ﹤0.01% 2783
2022
Q3 		$29K Sell
129
-6,595
-98% -$1.33M ﹤0.01% 2784
2022
Q2 		$849K Buy
6,724
+1,515
+29% +$174K ﹤0.01% 2037
2022
Q1 		$659K Sell
5,209
-698
-12% -$78.6K ﹤0.01% 2141
2021
Q4 		$772K Buy
5,907
+5,628
+2,017% +$727K ﹤0.01% 2282
2021
Q3 		$34K Sell
279
-724
-72% -$83.6K ﹤0.01% 2970
2021
Q2 		$114K Hold
1,003
– – ﹤0.01% 3036
2021
Q1 		$120K Sell
1,003
-5,852
-85% -$663K ﹤0.01% 2942
2020
Q4 		$696K Buy
6,855
+5,427
+380% +$503K ﹤0.01% 2289
2020
Q3 		$110K Hold
1,428
– – ﹤0.01% 2965
2020
Q2 		$159K Buy
+1,428
New +$124K ﹤0.01% 2779

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Russell Investments Group's KRTX Position: Q1 2024 in Review

Russell Investments Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 127 shares — an estimated $40.2K sold.

Russell Investments Group first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $1.76M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Russell Investments Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Russell Investments Group sold 127 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $40.2K.
  • Russell Investments Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Russell Investments Group's Karuna Therapeutics, Inc. Common Stock position peaked at $1.76M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.